Bio Matrix Scientific Group Inc (OTCPINK: BMSN) decreased 4.0% to $0.0024 on a traded volume 6.79 million shares. So far this year, the stock is up over 50%. The wholly owned subsidiary of Bio-Matrix Scientific Group Inc, RegenBioPharma published peer reviewed medical journal the scientific basis for its HemaXellerate bone marrow failure product. Bio Matrix Scientific Group is in the business of designing, developing and marketing medical devices, specifically disposable instruments used in stem cell extraction and tissue transfer procedures and operating cryogenic cellular storage facilities, specifically stem cell banking facilities.
Will BMSN Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=BMSN
CereplastInc (OTCQB: CERP) surged up 13.55% to $0.0310 on a traded volume of 5.13 million shares. The Company said that it is reducing its workforce. The Company is reducing its worldwide headcount to 17.
The Company has created additional liquidity through the generation of approximately $500,000 in revenue over the last six weeks while continuing to focus on restructuring its operations to further position the Company for growth throughout 2013.Cereplast designs and manufactures proprietary bio based, sustainable bio plastics which are used as substitutes for traditional plastics in all major converting processes.
Tranzbyte Corporation (OTCPINK: ERBB) soared 9.09% to $0.0036 on a traded volume of 19.77 million shares. The Company said that its current Board of Directors has been re-elected to serve another term. David Gwyther, Tranzbyte's president, announced that he and Colleen Manley have been elected to serve an additional one year term as Tranzbyte's board of directors.
Peregrine Pharmaceuticals (NASDAQ: PPHM) decreased 2.42% to $2.02 on a traded volume of 841k shares. Recently, the Company filed SEC Form 4 related to statement of changes in beneficial ownership of securities.
Roth Capital increased the rating of Peregrine Pharmaceuticals from a neutral rating to a buy rating in a research report released. Roth Capital currently has $2.70 price target on the stock.
All American Pet Co Inc (OTCQB: AAPT) soared 15.85% to $0.0190. The Company is filling its initial Purchase Orders from the world's largest retailer. No other retailer has the power to instantly popularize a new brand. All American Pet Company is a developer and marketer of pet wellness products including dog foods and antibacterial wipes. The Company produces, markets and sells dog food under the brand names Grrrnola Natural Dog Food and Chompions.
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA